GV20 Therapeutics (United States)

Recent papers from GV20 Therapeutics (United States)

1. Abstract 3914: IGSF8 is a novel innate immune checkpoint and cancer immunotherapy targetCancer Research · 2024
2. Protocol for fast clonal family inference and analysis from large-scale B cell receptor repertoire sequencing dataSTAR Protocols · 2024
3. Anti CD161 Antibody IMT-009 Is a Novel Immunotherapeutic Agent That Effectively Blocks the Inhibitory CLEC2D/CD161 Axis in CLEC2D+ B Cell Hematological Malignancies Reinvigorating T and NK Cell Function Leading to Anti-Tumor BenefitBlood · 2023
4. Fast clonal family inference from large-scale B cell repertoire sequencing dataCell Reports Methods · 2023
5. T1K: efficient and accurate KIR and HLA genotyping with next-generation sequencing data2022
6. Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragmentsmAbs · 2020